Please login to the form below

Not currently logged in

New CSO for Sanofi

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer, effective September 1, 2011

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer effective, September 1, 2011.

Based in Paris, France, Gros will oversee all Sanofi's business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management.

He will report to Sanofi's' CEO, Christopher A Viehbacher.

Commenting on the appointment, Viehbacher said: "David-Alexandre brings a wealth of experience as a physician, strategic consultant and investment banker. He will be able to contribute significantly to the development and implementation of Sanofi's strategy and transformation."

Gros' previous positions include acting as an advisor to healthcare companies as principal of the healthcare investment banking division at Centerview Partners, as well as holding senior positions at Merrill Lynch and McKinsey & Company.

He was also resident physician at the University of Pennsylvania Health System from 1999 to 2000.

30th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...